By Andrew M. Potts The Pharmaceutical Benefits Advisory Committee (PBAC) has rejected a submission to add the human papillomavirus (HPV) vaccine Gardasil to the Pharmaceutical Benefits Scheme (PBS) for use in males. Gardasil is currently only available on the PBS for girls through the National Immunisation Program (NIP) to combat cervical cancer. Last year, drug […]
Merck Dodges FDA Bullet and Wins Approval for Gardasil Expansion from Health Canada
By Leslie Carol Botha, Vice President Public Relations, SaneVax Inc. PRLog (Press Release) – May 02, 2011 – SANE Vax Inc. is highly disturbed Merck has not taken FDA advice to prove vaccine efficacy in 26 to 45 year old women prior to getting approval from other governments for use in this age group. According […]
Emily Tarsell Writes Letter of Concern to N. Carolina School Board – HPV Vaccine Risks
Emily Tarsell ________________________________________________________________________________________________________________________________________________ 2314 Benson Mill Road Sparks, Maryland 21152 Chapel Hill-Carrboro City Schools Attention: Members of the School Board 750 South Merritt Mill Road Chapel Hill, NC 27516 April 30, 2011 Dear School Board Members; It is unusual for a Marylander to write to a North Carolina school board, but I do so […]
SANE Vax. Inc Addresses Global Concerns about HPV Vaccines
The Weekly Blitz Dhaka by Christina England April 27, 2011 In March this year, the British Society for Ecological Medicine held their spring conference in London. The conference entitled ‘A tablet a day keeps the patient at bay-The Health Hazards of Prevention -Vaccinations and Pharmacoprophylax’ brought together experts from around the world to speak on […]
Canada Approves Gardasil For Use In Most Women
By Ed Silverman Less than a month after the FDA refused to approve the Gardasil vaccine for preventing HPV in women ages 27 to 45, Health Canada has gone in the other direction and issued an endorsement. Although Canada is a smaller market than the US, the approval is a notable step for Merck, which […]
- « Previous Page
- 1
- …
- 111
- 112
- 113
- 114
- 115
- …
- 240
- Next Page »
